Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody

Catalog No. ABIN7829099

The Humanized Monoclonal anti-CTLA-4 (Tremelimumab Biosimilar) antibody is suitable to detect CTLA-4 (Tremelimumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody (ABIN7829099)

Target: CTLA-4 (Tremelimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CTLA-4 (Tremelimumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CTLA-4 (Tremelimumab Biosimilar) Antibody

Purpose: Anti-CTLA-4(tremelimumab biosimilar) mAb

Isotype: IgG2

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CTLA-4 (Tremelimumab Biosimilar)

Target: CTLA-4 (Tremelimumab Biosimilar)

Alternative Name: Tremelimumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD,GSE,GRD4,ALPS5,CD152,CTLA-4,IDDM12,CELIAC3
Synonyms Antibody:CP-675,CP675,CP 675,CP-675206,CP 675206,CP675206,IMJUDO,Ticilimumab

UniProt: P16410